[18F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)

18F-Choline PET/MRI: The additional value of PET for MRI-guided transrectal prostate biopsies

A better way to image metastatic prostate cancer

Acquisition with 11C-choline and 18F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: A systematic review and meta-analysis

AR protein in prostate cancer detected with new imaging technique

Call for hospitals to use high-tech scans to diagnose prostate cancers when they can still be cured

First patient dosed with PyL, a PSMA-targeted PET/CT imaging agent for prostate cancer

How prostate cancer cells mimic bone when they metastasize

Imaging test accurately detects extent of prostate cancer in patients

London researchers first in Canada to use improved prostate cancer imaging

Molecular imaging biomarker able to detect high-grade prostate cancer

Molecular imaging study reveals improved detection of early recurrent prostate cancer

New imaging method can detect, monitor and guide treatment for prostate cancer

New PET imaging agent detects metastatic prostate cancer

New type of PET imaging identifies primary and metastatic prostate cancer

NICE OK’s restricted use of Bayer’s prostate cancer drug

Novel technique may improve detection of aggressive prostate cancer

Patterns of failure after radical prostatectomy in prostate cancer – implications for radiation therapy planning after 68Ga-PSMA-PET imaging: Beyond the Abstract

PET-MRI combination may change management of high-risk cancer patients

PET/CT beats CT and bone scans for detecting metastatic prostate cancer: study